NCT07029399
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07029399
Title A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors NiKang Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center RECRUITING La Jolla California 92037 United States Details
Sarah Cannon Research Institute at HealthONE RECRUITING Denver Colorado 80218 United States Details
Yale Cancer Center RECRUITING New Haven Connecticut 06520 United States Details
SCRI Florida Cancer Specialists - Sarasota RECRUITING Sarasota Florida 34232 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02115 United States Details
South Texas Accelerated Research Therapeutics (START) Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
Washington University RECRUITING St Louis Missouri 63110 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44195 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics (START) San Antonio RECRUITING San Antonio Texas 78229 United States Details
South Texas Accelerated Research Therapeutics (START) Mountain Region RECRUITING West Valley City Utah 84119 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field